What happened?
Polymarket, best known as a prediction market platform, has launched trading in perpetual futures (or "perps"). According to Incrypted [1], the new product offers leverage up to 20x and allows trading of cryptocurrencies, stocks, commodities, and other assets.
Perpetual futures are derivative contracts with no expiration date. Unlike traditional futures, they have no fixed settlement term and track the price of the underlying asset through a funding mechanism (funding rate). Leverage means a trader controls a position larger than their deposited capital; 20x leverage magnifies both potential profit and potential loss twentyfold relative to the trader's own deposit.
According to the cited communication [1], Polymarket promotes the product as a solution with the "deepest liquidity and lowest fees." This is a marketing claim from the platform, not an independently verified figure, and we flag it as such.
Why is Polymarket doing this now?
According to Incrypted [1], the new product arrives at a time when the platform is dealing with both investment and regulatory troubles in various countries. The specific list of jurisdictions, the scale of the investments, and the details of the regulatory disputes do not clearly emerge from the available source, so we do not present them as fact here.
Charlie perspective: launching derivatives is a major step away from the original model for a prediction platform. What began as a market for betting on event outcomes is also becoming a place where you can trade leveraged positions on ordinary assets. Whether it will work and how regulators will respond remains open for now.
How does this fit into the broader picture around perpetual futures?
In recent months, perpetual futures have been moving from the purely crypto world into more traditional finance and to regulated players.
| Player | Move | Source |
|---|---|---|
| Polymarket | Launch of "Perps" with leverage up to 20x on crypto, stocks, commodities | [1] |
| Binance Futures | Announcement of launching more USDⓈ-margined TradFi perpetual contracts | [2] |
| CFTC vs. CME | CFTC asks court to dismiss CME's lawsuit over crypto perpetual futures | [3][4] |
According to its announcement [2], Binance is preparing several perpetual contracts tied to traditional financial assets, settled in stablecoins (USDⓈ-margined). This shows that multiple large platforms are simultaneously working to bridge TradFi and crypto derivatives.
What is happening on the U.S. regulatory front?
The U.S. Commodity Futures Trading Commission (CFTC) has asked a court to dismiss a lawsuit filed by exchange group CME over crypto perpetual futures. According to Cointelegraph [3], CFTC lawyers described the lawsuit as "much ado about nothing" and argued that CME lacks active standing to file it.
Decrypt [4] adds the core of the dispute: the CFTC argues that CME cannot challenge the approval of Kalshi's Bitcoin perpetual contract without demonstrating specific financial harm. It is therefore a legal dispute over who is even allowed to challenge the approval of such products.
The connection to Polymarket is indirect. But they share the same theme: the regulatory framework for perpetual futures outside traditional crypto exchanges is still taking shape and is also being decided in court.
What we do not yet know
- The exact launch date of the Polymarket product and its geographic availability.
- The actual level of fees and depth of liquidity (the platform claims "lowest fees," which we have not verified independently).
- Which specific regulators and which specific disputes Incrypted [1] refers to.
- How (and whether) the Polymarket product relates to the U.S. regulatory environment described in the CFTC vs. CME dispute [3][4].
What to watch out for with this type of product
20x leverage means that even a small price move against a position can lead to liquidation of the deposit. Perpetual contracts also involve a funding rate, which continuously shifts payments between long and short positions. This is not trading advice, just a description of the mechanics of the product we are writing about.